National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

vaccinia-PSA-TRICOM vaccine
A vaccine formulation consisting of recombinant vaccinia virus encoding prostate specific antigen (PSA) and recombinant vaccinia virus encoding three co-stimulatory molecule transgenes B7.1, ICAM-1, and LFA-3 (TRICOM). Vaccination with PSA in combination with TRICOM may enhance antigen presentation, resulting in the augmentation of a cytotoxic T cell (CTL) immune response against tumor cells expressing PSA. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Synonym:vaccinia-prostate-specific antigen-TRICOM vaccine
Abbreviation:vPSA-TRI



Previous:Uvadex, Uvidem, V930 vaccine, vaccine-sensitized draining lymph node cells, vaccinia virus (vvDD-CDSR)
Next:vaccinia-tyrosinase vaccine, Vagestrol, valacyclovir, Valcyte, valdecoxib

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov